Clik here to view.
DePuy sponsor’s Anika’s IDE bid for Monovisc hip treatment
Anika Therapeutics (NSDQ:ANIK) said today that DePuy Orthopedics will support its submission of an investigational device exemption to conduct a trial to expand the indication of Monovisc for the...
View ArticleClik here to view.
J&J’s DePuy Synthes Trauma debuts Conform Flex biologic implant for...
Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Synthes Trauma today debuted its Conform Flex biologic implant for extremities repair in the U.S. Conform Flex is a pre-hydrated demineralized...
View ArticleClik here to view.
Surgical funder ordered to turn over information on DePuy hip surgeries
(Reuters) — A federal judge yesterday ordered a surgical funding company to turn over information about payments it made to healthcare providers for surgeries performed on plaintiffs suing over...
View ArticleClik here to view.
Johnson & Johnson escapes DePuy Pinnacle hip implant lawsuit
Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopaedics yesterday won the dismissal of a False Claims Act lawsuit brought by a pair of British surgeons over its since-discontinued Pinnacle...
View ArticleClik here to view.
Jury slaps Johnson & Johnson with $500m verdict in Pinnacle hip bellwether
A Texas federal jury today slapped Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopaedics with a $500 million judgment in favor of a quintet of plaintiffs who said the metal-on-metal Pinnacle...
View ArticleClik here to view.
Johnson & Johnson’s DePuy picks up BioMedical Enterprises
Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopaedics said yesterday that it acquired BioMedical Enterprises, which makes implants for small bone fixation, for an undisclosed amount. San...
View ArticleClik here to view.
Johnson & Johnson wants Pinnacle bellwethers stayed after $500m loss
A Johnson & Johnson (NYSE:JNJ) subsidiary wants a federal appeals court to hit the pause button in the multi-district litigation over its Pinnacle metal-on-metal hip implant to give it enough time...
View ArticleClik here to view.
J&J’s DePuy can’t delay 3rd bellwether in Pinnacle hip MDL
A Johnson & Johnson (NYSE:JNJ) subsidiary can’t delay an upcoming bellwether trial in the multi-district litigation over its Pinnacle metal-on-metal hip implant, a federal judge in Texas ruled...
View ArticleClik here to view.
Judge slashes $500m jury verdict to $151m in J&J’s Pinnacle hip loss
A federal judge yesterday slashed a $500 million verdict against Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopaedics in the multi-district litigation over its Pinnacle metal-on-metal hip...
View ArticleClik here to view.
Johnson & Johnson’s DePuy wants expedited appeal of $151m Pinnacle hip loss
Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopaedics asked a federal appeals court this week to expedite the appeal of its $151 million loss in a product liability lawsuit brought over its...
View ArticleClik here to view.
Plaintiff’s $8m win in DePuy ASR hip trial survives Johnson & Johnson’s appeal
An $8 million plaintiff’s award in a product liability lawsuit brought over the DePuy ASR XL metal-on-metal hip implant made by Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopaedics survived...
View ArticleClik here to view.
Jury levels $1B verdict against J&J’s DePuy Ortho in Pinnacle hip bellwether
UPDATED Dec. 2, 2016, with quotes from plaintiff’s and defense attorneys and DePuy Orthopedics. A federal jury in Dallas today ordered Johnson & Johnson (NYSE:JNJ) and its subsidiary DePuy...
View ArticleClik here to view.
Judge cuts $1B verdict against J&J in DePuy Pinnacle hip implant suit
A federal judge in Texas again slashed a large jury verdict against Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopaedics over its metal-on-metal Pinnacle hip implant, nearly halving the $1...
View ArticleClik here to view.
Johnson & Johnson seeks new trials after $1B Pinnacle hip implant loss
Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopaedics wants a federal judge to grant new trials after it lost a $1 billion judgment to 6 plaintiffs who sued over its metal-on-metal Pinnacle...
View ArticleClik here to view.
Ex-Johnson & Johnson exec wins appeal in noncompete spat with Baxter
A former Johnson & Johnson (NYSE:JNJ) executive won her appeal in a dispute over her non-compete contract that arose after she moved to Baxter (NYSE:BAX). Laura Angelini, now the GM for Baxter’s...
View Article
